5Ng JC, Wang J, Shraim A. A global health problem caused by arsenic from natural sources [J]. Chemosphere,2003,52 (9): 1353-1359.
6Waalkes MP, Liu J. Purine Nucleoside Phosphorylase: A Fortuitous Cytosolic Arsenate Reductase[J]. Toxicol Sci, 2002,70(1):1-3.
7Bantia S, Kilpatrick JM. Purine nucleoside phosphorylase inhibitors in T-cell malignancies[J]. Curr Opin Drug Discov Devel,2004, 7(2) :243-247.
8Yu L, Kalla K, Guthrie E, et al. Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans [J]. Environ Health Perspect,2003,111 (11): 1421-1427.
9Nemeti B, Csanaky I, Gregus Z. Arsenate reduction in human erythrocytes and ratstesting the role of purine nucleoside phosphorylase[J]. Toxicol Sci, 2003,74(1) :22-31.
10Strange RC, Spiteri MA, Ramachandran S,et al. Glutathione-S-transferase family of enzymes[J]. Mutation Research, 2001, 482(1-2) :21-26.
2Mass MJ, Wang LJ. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung ceils:A model for a mechanism of carcinogenesis. Mutation Res,1997,386: 263-277.
3Zhong CX, Mass MJ. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett,2001, 122:223-234.
4Chen H, Liu J, Zhao CQ, et al. Association of c-myc overexpression and hyperprolfferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol, 2001,175:260-268.
5Zhao CQ, Matthew R, Diwan BA, et al. Association of arsenicinduced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA,1997,94:10907-10912.
6Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996,93:9821-9826.
7Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTSI gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995,55:4525-4530.
8Hsu CH, Yang SH, Wang JY, et al. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Brit J Cancer, 1999,80:1080-1086.
